<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="320662">
  <stage>Registered</stage>
  <submitdate>16/09/2010</submitdate>
  <approvaldate>24/09/2010</approvaldate>
  <actrnumber>ACTRN12610000792022</actrnumber>
  <trial_identification>
    <studytitle>Prevalence of Concurrent Deep Vein Thrombosis in Patients with Lower Limb Cellultis</studytitle>
    <scientifictitle>Prevalence of Concurrent Deep Vein Thrombosis in Patients with Lower Limb Cellultis</scientifictitle>
    <utrn>U1111-1111-0324</utrn>
    <trialacronym>N/A</trialacronym>
    <secondaryid>None</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Cellulitis of the lower limb</healthcondition>
    <healthcondition>Deep vein thrombosis</healthcondition>
    <conditioncode>
      <conditioncode1>Infection</conditioncode1>
      <conditioncode2>Other infectious diseases</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Blood</conditioncode1>
      <conditioncode2>Clotting disorders</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>All patients with lower limb cellulitis will be investigated for concurrent deep venous thrombosis. This will be through application of the Wells score, which is a clinical assessment tool for assessing the probability of deep vein thrombosis, a D-dimer blood test and if neccessary an ultrasound scan of the deep venous system. This will occur once at recruitment.</interventions>
    <comparator>nil.</comparator>
    <control>Uncontrolled</control>
    <interventioncode>Diagnosis / Prognosis</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Prevalence of concurrent deep venous thrombosis in patients with cellulitis of the lower limb</outcome>
      <timepoint>At time of diagnosis</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Predictive value of the Wells score in this population. The Wells score is a clinical assessment tool for assessing the probability of deep vein thrombosis.</outcome>
      <timepoint>At time of diagnosis</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Patients admitted to Christchurch Hospital with lower limb cellulitis</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>nil</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Diagnosis</purpose>
    <allocation>Non-randomised trial</allocation>
    <concealment>All patients admitted with lower limb cellulitis will be approached by a member of the clinical team.</concealment>
    <sequence>N/A</sequence>
    <masking>Open (masking not used)</masking>
    <assignment>Single group</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>1/07/2010</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>200</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Closed: follow-up complete</recruitmentstatus>
    <recruitmentcountry />
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state>Canterbury</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>Canterbury District Health Board</primarysponsorname>
    <primarysponsoraddress>Christchurch Hospital
Riccarton Ave
Private Bag 4710
Christchurch
8011</primarysponsoraddress>
    <primarysponsorcountry>New Zealand</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>Canterbury District Health Board</fundingname>
      <fundingaddress>Christchurch Hospital
Riccarton Ave
Private Bag 4710
Christchurch
8011</fundingaddress>
      <fundingcountry>New Zealand</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Both lower limb cellulitis and deep vein thrombosis are common conditions that share some clinical features. This often leads to the investigation of possible deep vein thrombosis in patients with cellulitis. The result of a retrospective audit suggested that the rate of deep vein thrombosis in patients is low. This study would assess in a prospective way, the rate of deep venous thrombosis in patients with cellulitis. It would also assess the specificity of the currently used assessment criteria for possible deep vein thrombosis in patients with cellulitis.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Upper South Regional Ethics Committee (NZ)</ethicname>
      <ethicaddress>C/- Ministry of Health
4th floor 
250 Oxford Terrace 
PO Box 3877
Christchurch
8011</ethicaddress>
      <ethicapprovaldate />
      <hrec>N/A</hrec>
      <ethicsubmitdate>1/10/2009</ethicsubmitdate>
      <ethiccountry>New Zealand</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Michael Maze</name>
      <address>Dept. Infectious Diseases
Christchurch Hospital
Riccarton Ave
Private Bag 4710
Christchurch
8011</address>
      <phone>+64 3 3640951</phone>
      <fax>+64 3 3640952</fax>
      <email>Michael.Maze@cdhb.govt.nz</email>
      <country>New Zealand</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Michael Maze</name>
      <address>Dept. Infectious Diseases
Christchurch Hospital
Riccarton Ave
Private Bag 4710
Christchurch
8011</address>
      <phone>+64 3 3640640</phone>
      <fax />
      <email>Michael.Maze@cdhb.govt.nz</email>
      <country>New Zealand</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Michael Maze</name>
      <address>Dept. Infectious Diseases
Christchurch Hospital
Riccarton Ave
Private Bag 4710
Christchurch
8011</address>
      <phone>+64 3 3640640</phone>
      <fax />
      <email>Michael.Maze@cdhb.govt.nz</email>
      <country>New Zealand</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>